We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 235

Industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • December 16 2014

The Patented Medicine Prices Review Board (PMPRB) has released a new report titled "Generic Drugs in Canada, 2013", which compares the prices of

Antibody patent found valid and infringed

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 27 2014

The Court recently decided a patent infringement case dealing with antibodies. The claims at issue in AbbVie’s patent relate to the use of a human

Bayer v. Minister of Health

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 28 2010

The Court of Appeal upheld the decision of the Federal Court, dismissing the application by Bayer for a review of the decision of the Minister of Health refusing to list a patent on the Patent Register in respect of its drug product

Motion for additional rebuttal witnesses in re-opened trial denied

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • November 28 2011

The Defendants brought a motion seeking to call rebuttal witnesses in a trial that has been re-opened to allow evidence that may contradict the evidence given at trial

Court of Appeal upholds decision relating to sildenafil use patent

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 27 2014

Pfizer Ireland Pharmaceuticals v. Apotex Inc., 2014 FCA 13 Drug: VIAGRA sildenafil In Apotex' action for impeachment of the Pfizer patent

Pleadings amendments refused on the eve of trial

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 7 2011

BMS brought a motion to strike out certain amendments made to its pleadings by Apotex

Glaxo Group v. Apotex

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • August 11 2010

The Court had granted Apotex's application seeking an Order that Glaxo's trademark be expunged

Other industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 18 2012

Health Canada sent an Annual Drug Notification Form to the DIN holder of drugs currently marketed in Canada

With quantum of damages settled, parties unable to agree on quantum of costs or calculation of pre- and post-judgment interest in Section 8 case

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • August 14 2014

In the Federal Court’s earlier decision (summary here), the parties were instructed to attempt to reach an agreement on the quantity of damages and

Patent not eligible for listing: patent claiming one medicinal ingredient,but directed to a fixed-dose combination of medicines

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 15 2014

This was an appeal from two decisions for three proceedings before Prothonotary Milczynski, in which she determined that a patent could not be listed